Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Mesa Laboratories (MLAB) EPS (Weighted Average and Diluted) (2016 - 2025)

Mesa Laboratories (MLAB) has disclosed EPS (Weighted Average and Diluted) for 16 consecutive years, with $0.65 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 309.68% to $0.65 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $0.65 through Dec 2025, up 101.4% year-over-year, with the annual reading at -$0.36 for FY2025, 99.24% up from the prior year.
  • EPS (Weighted Average and Diluted) hit $0.65 in Q4 2025 for Mesa Laboratories, up from $0.45 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.85 in Q2 2025 to a low of -$47.26 in Q1 2024.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$2.22 across 5 years, with a median of $0.18 in 2023.
  • Biggest YoY gain for EPS (Weighted Average and Diluted) was 720.0% in 2024; the steepest drop was 43063.64% in 2024.
  • Year by year, EPS (Weighted Average and Diluted) stood at -$0.39 in 2021, then skyrocketed by 120.51% to $0.08 in 2022, then skyrocketed by 387.5% to $0.39 in 2023, then tumbled by 179.49% to -$0.31 in 2024, then soared by 309.68% to $0.65 in 2025.
  • Business Quant data shows EPS (Weighted Average and Diluted) for MLAB at $0.65 in Q4 2025, $0.45 in Q3 2025, and $0.85 in Q2 2025.